Table 1.
Effect of Treatment with Anti-α1 Antibody on NTN at Day 10
| Treatment group | Albuminuria (mg/day) | Glomerular crescents (%) | Creatinine clearance (ml/min) |
|---|---|---|---|
| Anti-α1 | 166 ± 24 | 55 ± 11 | 1.0 ± 0.1 |
| Control | 207 ± 19 | 50 ± 2 | 1.1 ± 0.01 |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.